6-aMino-9-benzyl-2-(2-Methoxyethoxy)-9H-purin-8-ol Chemical Properties

Density 

1.356

storage temp. 

Store at -20°C

solubility 

DMF: 30 mg/ml; DMSO: 30 mg/ml; DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml

form 

A crystalline solid

color 

White to off-white

6-aMino-9-benzyl-2-(2-Methoxyethoxy)-9H-purin-8-ol Usage And Synthesis

Uses

SM-360320 (CL-087) is a potent, orally active TLR7 agonist. SM-360320 is a immuno-modulator and exerts an antitumor effect. SM-360320 can act in synergy with DNA vaccines leading to an enhanced Th1 antibody response[1]. SM-360320 can inhibit HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity[2].

References

[1] Dharmapuri S, et al. An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models. Cancer Gene Ther. 2009;16(5):462-472. DOI:10.1038/cgt.2008.91
[2] Lee J, et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A. 2006;103(6):1828-1833. DOI:10.1073/pnas.0510801103

6-aMino-9-benzyl-2-(2-Methoxyethoxy)-9H-purin-8-ol(226907-52-4)Related Product Information

• SMI-4a
• N-(4-BroMophenyl)-3,5-diMethyl-1-piperidinepropanaMide Hydrochloride
• 2-(6-amino-5-(piperazin-1-yl)pyridazin-3-yl)phenol hydrochloride
• SM1-71
• (4-Chloro-3-nitrophenyl)(4-(2-fluorophenyl)piperazin-1-yl)Methanone
• SM 7368
• SMI-16a
• SM-276001